|Systematic (IUPAC) name|
|Mol. mass||597.891 g/mol|
|Metabolism|| Hydrolyzed to active metabolites|
CYP system not involved
|Half life||141 minutes (mean)|
|Excretion||Renal and fecal|
Rapacuronium bromide (trade name Raplon, Organon) is a rapidly acting, non-depolarizing neuromuscular blocker used in modern anaesthesia, to aid and enable endotracheal intubation, which is often necessary to assist in the controlled ventilation of unconscious patients during surgery and sometimes in intensive care. As a non-depolarizing agent, it does not cause initial stimulation of muscles before weakening them.
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies